looking for promising clinical trials for pancreatic cancer that cant be treated by surgery?

byMedMaven

Sep 16, 2018

Comments (1)

No. 1-1

MedMaven

Editor

Sep 16, 2018

These vaccine trials at Hopkins look promising:

Dual Vaccines Prolong Survival in Metastatic Pancreatic Cancer - Cancer Connect

John Hopkins doctors update results on GVAX vaccine trial for pancreatic cancer

mavendoctors.io

Pancreatic Cancer Treatment and Management

Understand the role of surgery, chemotherapy and precision cancer medicines for treatment of pancreatic cancer.

Cancer Connect

Dec 17, 2019

PARP Inhibitors Shows Promise as Treatment for Pancreatic Cancer

PARP Inhibitor Lynparza - first precision cancer medicine approved for treatment of pancreatic cancer.

Cancer Connect

Dec 16, 2019

Overview of Pancreatic Cancer

Symptoms, risk factors, diagnosis, screening and prevention of pancreatic cancer.

Cancer Connect

Jun 11, 2019

Treatment of Stage IV - Metastatic Pancreatic Cancer

Treatment is with precision medicines & chemotherapy - genomic biomarker testing should be performed in all patients.

Cancer Connect

Jun 11, 2019

Aspirin May Decrease Pancreatic Cancer Risk

Aspirin—but not other types of non-steroidal anti-inflammatory drugs (NSAIDs)—may reduce the risk of pancreatic cancer.

Cancer Connect

Jun 1, 2018

NRG 1 Fusion Genes Can be Targeted with the MCLA-128 Bispecific Antibody

Responses to MCLA-128 reported in patients with pancreatic ductal adenocarcinoma and non-small cell lung cancer.

MedMaven

Nov 18, 2019

Early Activity in Pancreatic Cancer with Adavosertib

Experimental Gemzar-Adavosertib- Radiation combination promising for treatment of locally advanced pancreatic cancer.

MedMaven

Sep 21, 2019

FDA Approves Tarceva® in Combination with Gemzar® for Pancreatic Cancer

Cancer Connect

Jun 1, 2018

Data Associating Being Overweight with Increased Risk of Pancreatic Cancer

Further Data Associating Being Overweight with Increased Risk of Pancreatic Cancer

Cancer Connect

Jun 1, 2018

BL- 8040 - A Novel CXCR4 Blocking Agent for Pancreatic Cancer

Triplet immunotherapy - BL-8040 combination shows promising responses in metastatic pancreatic cancer.

MedMaven

Dec 27, 2019

Cancer Connect

theRAconnection

The Spine Community

Women's Health

Osteoporosis